Inverness Medical Innovations (NYSE:[[ticker:IMA]]), a Waltham, MA-based provider of medical diagnostics and health management services, says that it plans to raise $200 million through a public offering of senior subordinated notes due in 2016. The proceeds of the debt offering will be used for general corporate purposes, according to Inverness. The company filed documents with the SEC on April 10 to disclose that it may complete offerings to raise funds, and the firm says that the $200 million notes sale will be done under that SEC filing.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
